Clearmind Medicine (CMND) Competitors $1.03 +0.01 (+0.98%) As of 02:44 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CMND vs. SYBX, IXHL, EDSA, THAR, AIMD, TLPH, IBIO, MTVA, CARM, and CLRBShould you be buying Clearmind Medicine stock or one of its competitors? The main competitors of Clearmind Medicine include Synlogic (SYBX), Incannex Healthcare (IXHL), Edesa Biotech (EDSA), Tharimmune (THAR), Ainos (AIMD), Talphera (TLPH), iBio (IBIO), MetaVia (MTVA), Carisma Therapeutics (CARM), and Cellectar Biosciences (CLRB). These companies are all part of the "pharmaceutical products" industry. Clearmind Medicine vs. Its Competitors Synlogic Incannex Healthcare Edesa Biotech Tharimmune Ainos Talphera iBio MetaVia Carisma Therapeutics Cellectar Biosciences Synlogic (NASDAQ:SYBX) and Clearmind Medicine (NASDAQ:CMND) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and media sentiment. Is SYBX or CMND more profitable? Synlogic's return on equity of -8.09% beat Clearmind Medicine's return on equity.Company Net Margins Return on Equity Return on Assets SynlogicN/A -8.09% -5.50% Clearmind Medicine N/A -173.87%-70.55% Which has stronger valuation and earnings, SYBX or CMND? Clearmind Medicine has lower revenue, but higher earnings than Synlogic. Synlogic is trading at a lower price-to-earnings ratio than Clearmind Medicine, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSynlogic$10K1,883.70-$23.36M-$0.08-20.13Clearmind MedicineN/AN/A-$5.26M-$0.76-1.36 Do insiders and institutionals hold more shares of SYBX or CMND? 63.4% of Synlogic shares are held by institutional investors. Comparatively, 96.1% of Clearmind Medicine shares are held by institutional investors. 3.0% of Synlogic shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more risk and volatility, SYBX or CMND? Synlogic has a beta of 0.54, indicating that its share price is 46% less volatile than the S&P 500. Comparatively, Clearmind Medicine has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500. Does the media prefer SYBX or CMND? In the previous week, Clearmind Medicine had 1 more articles in the media than Synlogic. MarketBeat recorded 3 mentions for Clearmind Medicine and 2 mentions for Synlogic. Synlogic's average media sentiment score of 1.45 beat Clearmind Medicine's score of 1.42 indicating that Synlogic is being referred to more favorably in the media. Company Overall Sentiment Synlogic Positive Clearmind Medicine Positive SummarySynlogic beats Clearmind Medicine on 6 of the 11 factors compared between the two stocks. Get Clearmind Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for CMND and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CMND and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CMND vs. The Competition Export to ExcelMetricClearmind MedicineMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.39M$2.83B$5.75B$10.27BDividend YieldN/A57.24%5.73%4.60%P/E Ratio-1.3623.3875.1826.37Price / SalesN/A532.07457.0688.69Price / CashN/A27.5625.8129.91Price / Book1.415.4013.256.28Net Income-$5.26M$32.95M$3.29B$270.67M7 Day Performance1.98%0.13%0.72%2.79%1 Month PerformanceN/A3.93%4.58%6.01%1 Year Performance-23.13%-2.90%73.44%26.05% Clearmind Medicine Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CMNDClearmind Medicine1.4303 of 5 stars$1.03+1.0%N/A-23.9%$4.39MN/A-1.36N/APositive NewsEarnings ReportShort Interest ↓Gap UpSYBXSynlogic1.6449 of 5 stars$1.48+0.7%N/A+13.6%$17.20M$10K-18.5080Positive NewsShort Interest ↓IXHLIncannex Healthcare0.1483 of 5 stars$0.55-6.3%N/A-66.4%$17.13M$10K-0.453Short Interest ↑Gap UpEDSAEdesa Biotech1.4528 of 5 stars$2.43+0.4%$5.00+105.8%-43.9%$17.03MN/A-1.8420Gap UpTHARTharimmune2.4526 of 5 stars$2.79-5.7%$17.00+509.3%+5.7%$16.85MN/A-0.462Gap DownAIMDAinos1.0716 of 5 stars$3.38-6.4%N/A+34.4%$16.82M$110.87K-0.6840Gap DownTLPHTalphera2.0094 of 5 stars$0.85+4.2%$5.00+486.2%+4.4%$16.81M$650K-2.1319IBIOiBio1.6885 of 5 stars$0.83-2.6%$5.00+500.4%-51.6%$16.80M$375K-0.48100Short Interest ↑MTVAMetaVia2.6051 of 5 stars$0.68-1.8%$7.50+1,006.2%N/A$16.70MN/A0.008CARMCarisma Therapeutics2.6167 of 5 stars$0.41+4.3%$1.93+365.1%-63.3%$16.59M$19.63M-0.2720Short Interest ↑CLRBCellectar Biosciences3.5154 of 5 stars$5.29+5.2%$375.00+6,988.8%-92.1%$16.06MN/A-0.2710Short Interest ↓ Related Companies and Tools Related Companies SYBX Competitors IXHL Competitors EDSA Competitors THAR Competitors AIMD Competitors TLPH Competitors IBIO Competitors MTVA Competitors CARM Competitors CLRB Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CMND) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clearmind Medicine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clearmind Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
